Effect of Ileocolonic Delivered Vitamins and an Anti-Inflammatory Diet on Crohn's Disease and Healthy Volunteers (Vita-GrAID)

  • STATUS
    Recruiting
  • End date
    Jul 1, 2025
  • participants needed
    510
  • sponsor
    University Medical Center Groningen
Updated on 11 August 2022
vitamin
crohn's disease
faecal calprotectin
mucosal inflammation
Accepts healthy volunteers

Summary

This study will evaluate if the Groningen Anti-Inflammatory Diet and the ileocolonic delivery of vitamin B2, B3 and C can positively influence the course of Crohn's disease and can positively alter the gut microbiome of Crohn's disease patients as well as healthy volunteers.

Description

It is becoming increasingly more well known that diet and the microbiome have a pivotal role in the development and course of inflammatory bowel diseases (IBD). Strict exclusive enteral nutrition (EEN) can induce remission in Crohn's Disease (CD) and is the standard treatment in paediatric CD. Implementing a restrictive diet in adults is difficult; adult patients do not tend to adhere to EEN. Recently, the CD-exclusion diet (CDED) combined with partial enteral nutrition demonstrated to be effective in CD-patients with flares.

Additionally, accumulating evidence suggests that intake of vitamins can influence disease course, mainly by beneficially modulating the gut microbiota and gut redox potential, especially if the vitamins can be delivered to the colon.

Nevertheless, no dietary guidelines are available to physicians and patients. Due to complaints of certain foods and patients' eagerness to postpone new flares, patients start experimenting with their food. As patients with CD are already often malnourished, this poorly substantiated experimenting puts them even more at risk for malnutrition and could have a potential negative effect on their disease outcomes. Next, quality of life of patients decreases and healthcare costs will rise. Therefore, both patients and physicians are in desperate need of evidence for an anti-inflammatory dietary advice in CD. As compliance to a diet increases when they are supported by family members, their household members will also be asked to participate in the study. Simultaneously studying their healthy family members will also provide information of the effect of this anti-inflammatory diet or intake of lieocolonic-delivered vitamins on their microbiome and markers of inflammation and oxidative stress.

Details
Condition Crohn Disease
Treatment Groningen Anti-Inflammatory Diet (GrAID), ColoVit capsule, ColoPulse-placebo capsule
Clinical Study IdentifierNCT04913467
SponsorUniversity Medical Center Groningen
Last Modified on11 August 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Participant understands the study procedures and signed an informed consent to participate in this study
Previously diagnosed with CD; Montreal classification: L1 (Ileal), L2 (colonic), or L3 (ileocolonic)
Low-mild disease activity (no clinically relevant symptoms and HBI<8 or CDAI <220)
Evidence of mucosal inflammation (faecal calprotectin ≥100 μg/g)
Able to attend to the outpatient clinic of the UMCG, Martini Hospital, MCL Leeuwarden or Isala
≥18 years of age
Able to use oral feeding and willing to undergo a dietary intervention (Follow a diet or use a vitamin B2/B3/C supplement or placebo)
Inclusion Criteria healthy volunteers
Participant understands the study procedures and signed an informed consent to participate in this study
Never been diagnosed with IBD or any other chronic inflammatory condition
Participant has no health conditions that would prevent him/her from fulfilling the study requirements as judged by the investigator on the basis of medical history and routine laboratory test results
Able to attend to the outpatient clinic of the UMCG, Martini Hospital, MCL Leeuwarden or Isala
≥18 year of age
Able to use oral feeding and willing to undergo a dietary intervention (Follow a diet or use a vitamin B2/B3/C supplement or placebo)

Exclusion Criteria

Life expectancy <12 months
Active Crohn's disease (HBI≥8 or CDAI>220), or expecting drug intervention within 3 months
Colonoscopy and colon cleansing in the past 3 months
Use antibiotics, probiotics (eg Yakult, Vifit, Activia) or specific prebiotics supplements 3 weeks prior to the start of the intervention
Use of vitamin/mineral supplements 1 week prior to the start of the intervention (except for vitamin D and/or calcium)
Use Methotrexate drugs or chronic use of antacids, H2 or proton-pump inhibitors
With a history of GI disorders or GI surgery that are likely to interfere with the pH-dependent mode of action of the Colovit-capsule
Patients with a pouch or stoma
Pregnant or breastfeeding (or foreseen pregnancy during dietary intervention period)
Swallowing disorders, not able to tolerate oral food, or use of tube feeding (EEN)
Previously proven anaphylactic reaction to foods included in the food boxes
Previously diagnosed with Celiac Disease or following a gluten-free diet
Following a vegetarian or vegan diet
Exclusion Criteria healthy subjects
Life expectancy <12 months
Previously diagnosed with IBD or any other chronic inflammatory condition
Colonoscopy and colon cleansing in the past 3 months
Use antibiotics, probiotics (eg Yakult, Vifit, Activia) or specific prebiotics supplements 3 weeks prior to the start of the intervention
Use of vitamin/mineral supplements 1 week prior to the start of the intervention (except for vitamin D and/or calcium)
With a history of GI disorders or taken drugs that are likely to interfere with mode of action of interventions, such as chronic use of antacids or proton-pump inhibitors
Abnormal clinical chemistry and haematology laboratory test results of clinical significance that in the judgment of the investigator would interfere with the participant's ability to comply with the study protocol (which might confound the interpretation of the study results), or put the participant at undue risk
Presence of a stoma
History or presence of cancer in the prior two years, except for non-melanoma skin cancer
Recent history of (within 12 months of screening visit) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as >60g (men) / 40g (women) pure alcohol per day (1.5 l / 1 l beer resp. 0.75 l / 0.5 l wine)
Pregnant or breastfeeding (or foreseen pregnancy during dietary intervention period) The method of contraception must be recorded in the source documentation
Swallowing disorders, not able to tolerate oral food, or use of tube feeding (EEN)
Previously proven anaphylactic reaction to foods included in the food boxes
Previously diagnosed with Celiac Disease or following a gluten-free diet
Following a vegetarian or vegan diet
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note